Cullinan Therapeutics
Phill Gallacher is an experienced professional in the field of clinical development operations and management. Currently serving as Senior Vice President of Clinical Development Operations and Clinical Program Management at Cullinan Therapeutics, Phill has previously held the position of Senior Vice President of Clinical Development Operations and Vice President of Global Clinical Operations at Aprea Therapeutics Inc. Prior experience includes roles at Biogen as Director of Program Leadership and Director of Global Clinical Operations, as well as Senior Clinical Program Lead in Global Clinical Operations. Additionally, Phill worked as a Senior Project Manager at PPD. Educational background includes a Bachelor of Science with Honors in Pharmacology from the University of Glasgow, obtained between 1992 and 1996.
This person is not in the org chart
This person is not in any teams
Cullinan Therapeutics
1 followers
Cullinan Therapeutics is dedicated to creating new standards of care for patients. We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class. Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.